Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03943160 · ClinicalTrials.gov registry record
Radial accEss for nAvigation to Your CHosen Lesion for Peripheral Vascular Intervention: REACH PVI
A clinical trial, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- 50
- Enrollment target
NCT03943160 is a clinical trial that has completed, run by Abbott Medical Devices. The registered enrollment target is 50 participants.
The verdict
NCT03943160 has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate acute clinical results of orbital atherectomy (OA) via radial artery access, including complication rates and cost effectiveness.
Interventions
- DEVICE Diamondback 360 Extended Length Orbital Atherectomy System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2019-06-11 |
| Est. Completion | 2019-12-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03943160
The ClinicalTrials.gov registry entry for NCT03943160 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Diamondback 360 Extended Length Orbital Atherectomy System is the first listed.
NCT03943160 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03943160 about?
NCT03943160 is a clinical study titled "Radial accEss for nAvigation to Your CHosen Lesion for Peripheral Vascular Intervention: REACH PVI". The objective of this study is to evaluate acute clinical results of orbital atherectomy (OA) via radial artery access, including complication rates and cost effectiveness.
What is the current status of trial NCT03943160?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2019-06-11. Estimated completion is 2019-12-11.
What interventions are being tested in trial NCT03943160?
The interventions under investigation include: Diamondback 360 Extended Length Orbital Atherectomy System (DEVICE).
Who is sponsoring clinical trial NCT03943160?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.